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Summary  
 
Hypoxia benefits undifferentiated pluripotent stem cell renewal, and 2-oxoglutarate (2OG) 
dioxygenases have been implicated in pluripotent stem cell induction and renewal. We show 
in human embryonic stem cells (hESC) that an ambient oxygen-induced oxidative stress 5 
response elicited by culture in a hypoxic atmosphere (0.5% O2) correlates with the 
expression of 2OG dioxygenases, which oxidize DNA (TET1, 2, 3) and histone H3 (KDM4C), 
the former reflected by elevation in genomic 5-hydroxymethylcytosine (5hmC). siRNA-
mediated targeting of KDM4C and TET1-3 induces hESC differentiation. Under ambient 
atmospheric oxygen (21% O2), exposure to a low inhibitory concentration of sodium arsenite 10 
(NaAsO2, IC10), as a model of chemically-induced oxidative stress, suppresses antioxidant 
gene expression, reduces mitochondrial membrane potential and induces hESC 
differentiation. Co-administration of the antioxidant N-acetyl-L-cysteine promoted anti-
oxidant, pluripotency and 2OG dioxygenase gene expression, elevated genomic 
hydroxymethylation and blocked induction of differentiation. Transient ectopic expression of 15 
KDM4C or TET1 in ambient atmospheric oxygen achieved the same. Our study 
substantiates a role for 2OG-dependent dioxygenases in hypoxia’s promotion of 
undifferentiated hESC self-renewal.  
 
 20 
Highlights 
 
• Hypoxia elevates 2OG-dependent KDM4C and TET mRNAs and genomic 5hmC in 
hESCs. 
• siRNA targeting of KDM4C and TET1-3 induces hESC differentiation.  25 
• In ambient atmospheric conditions, NaAsO2 induces oxidative stress, genomic 
demethylation and differentiation. 
• Co-administration of NAC, Hypoxia, or ectopic expression of KDM4C or TET1 protect 
against the effects of NaAsO2. 
 30 
 
 
 
 
 35 
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Introduction 
 
Efforts to exploit the potential of human embryonic stem cells (hESCs) and analogous 
induced pluripotent stem cells (hiPSCs) in regenerative medicine are ongoing. These include 
their use as source material for cell therapy products such as for the treatment of conditions 5 
characterised by acute or chronic cell loss (e.g. macular degeneration, repair of spinal cord 
trauma, Parkinson’s and Huntington’s diseases, cardiomyopathy; for up to date accounting 
go to www.clinicaltrials.gov) and in cell banking initiatives to provide a standardised resource 
for discovery (e.g. [1]). Such activities necessitate the implementation of best practices in 
cell culture defined by balance of cost, benefit and risk to efficacy and safety. A case in point 10 
is cell cultivation in an ambient atmosphere (21% O2 in air, commonly referred to as 
normoxia) vs hypoxic conditions (0.5 to 5% O2). Despite considerable evidence 
substantiating the merits of lower oxygen concentrations generally, and in hESC culture 
specifically (reviewed in [2] and elaborated further below), cultivation under atmospheric 
oxygen remains common practice. An improved understanding of the mechanisms of 15 
hypoxia-mediated benefits is likely to assist in changing practices. 
 
HESC culture in the range of 2-5% O2, commonly regarded as hypoxic relative to ambient 
atmosphere but also considered “physiologically normoxic”, has broadly been reported to 
improve undifferentiated colony morphology (e.g. compactness), diminish levels of 20 
spontaneous differentiation, increase cell proliferation rate, enhance expression of 
pluripotency markers, and is associated with a reduced incidence of chromosomal 
abnormalities ([3-6]). At a molecular level this has been reflected by oxygen-dependent 
changes in gene expression [7, 8] including i) upregulation of expression of hypoxia-
inducible factors at an mRNA or protein level, genes of the glycolytic pathway under their 25 
control, the cellular relocalisation and stabilisation of these hypoxia-inducible proteins [5], 
and also of the c-MYC proto-oncogene [9]; ii) upregulation of substrate attachment 
mechanisms mediated by specific integrin receptors and CD44 [10]; and iii) activation of 
Notch signalling [6]. Dioxygenases, specifically the 2-oxoglutarate (2OG)-dependent 
dioxygenases, are regarded as O2 sensors that can modulate cellular homeostasis in 30 
response to oxidative stress and constitute candidate mediators of ambient oxygen stress-
induced epigenetic changes. These include ten-eleven-translocation (TET) enzyme family 
members (TET1, 2, 3) which oxidise 5-methylcytosine (5mC) to 5-hydroxymethylcytosine 
(5hmC) and the Jumonji domain 2 (JMJD2)-containing proteins, also known as histone 
lysine (K)-specific demethylases (e.g. KDM2-7), which oxidise and thereby demethylate 35 
specific trimethylated histone residues. All TETs are expressed in mouse and human 
pluripotent stem cells, and TET1 has been shown to replace OCT4 in the induction of 
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pluripotency in mouse embryonic fibroblasts [11]. Both the TET1 and KDM4C genes in 
hESCs are uniquely epigenetically-marked, with distinctive patterns of gene-associated 
cytosine-guanine island methylation shown to be associated with proper maintenance of a 
pluripotent phenotype [12]. In mouse ESCs the histone H3-specific demethylase KDM4C 
has also been shown to act with NANOG in an interconnected regulatory loop, with depletion 5 
resulting in differentiation [13]. Genome-wide localisation analyses reveal enrichment of 
TET1 on regulatory regions marked with H3K4me3 alone or with H3K27me3 [14-16]. 
Collectively these studies implicate TET1 and KDM4C in the regulation of pluripotency and 
differentiation. 
We sought to investigate the relationship between ambient oxygen, oxidative stress and 10 
2OG dioxygenases in hESC renewal, and the potential of 2OG dioxygenases to mediate the 
known benefits of hypoxia. Specifically, we assessed; 1) the response of undifferentiated 
hESCs to culture in a hypoxic (0.5% O2) vs ambient normoxic (21% O2) atmosphere at the 
level of the oxidative stress response, expression of pluripotency genes, KDM4C and TET1-
3 expression and genomic methylation and hydroxymethylation; 2) the consequences of 15 
RNA interference with expression of KDM4C and TETs; and 3) ambient oxygen dependence 
of the hESC response to low inhibitory concentrations (IC10) of arsenic in the form of the 
organic metallic compound sodium arsenite (NaAsO2), a source of chemically-induced 
oxidative stress [17-21]. Sodium arsenite serves as a  model of organometallic 
contamination of a culture environment, such as could derive from water sources or 20 
pressurised atmospheric gas containers. Our findings suggest that hypoxia-induced 
oxidative stress elevates KDM4C and TET expression, associated with genomic DNA 
hydroxymethylation, and KDM4C and TETs provide protection against organometallic 
chemical induction of oxidative stress and cell differentiation.  
 25 
Results 
Our study replicated all experiments in two independent hESC lines to identify conserved 
outcomes irrespective of known epigenomic (e.g. [12, 22]) and genomic [23] variability 
between hESC lines. These were the H9 line [24] (main figures) broadly used as a reference 
standard [23], and the RH1 line derived and utilised by our laboratory [12, 25, 26] 30 
(supplementary figures). Conserved outcomes between cell lines are denoted throughout all 
figures by a solid inverted triangle (▼) with degree of statistical significance noted by 
asterisks as follows: *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. In the absence of a solid 
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inverted triangle symbol, the observed significance pertains only to the cell line depicted in a 
figure. 
Effect of hypoxia on hESC renewal, KDM4C and TET1-3.  
HESCs were cultured continuously for 7 days in feeder-free conditions on Matrigel in 
normoxia (21% O2 in air) or hypoxia (0.5% O2), one day after plating in normoxia. Both 5 
atmospheres maintained undifferentiated OCT4- and NANOG-positive colonies, although 
hypoxia significantly increased cell growth over the duration of the experiment (Fig./Suppl. 
Fig. 1 A-C; p<0.01). By ELISA, global genomic 5-hmC increased significantly although this 
was not qualitatively evident by immunofluorescence microscopy for 5-hmC or mC  
(Fig./Suppl. Fig. 1 C,D; p<0.01). Using RT-qPCR to assess mRNA steady state levels 10 
hypoxia increased the relative expression of pluripotency-associated transcription factors 
(OCT4, NANOG; p<0.01), and the 2OG dioxygenases KDM4C, TET1 (p<0.001) and TET3 
(p<0.05) (Fig./Suppl. Fig. 1E). Furthermore, hypoxia significantly increased levels of overall 
reactive oxygen species (ROS) after days 1 (p<0.001) and continuing to day 7 (p<0.05) 
(Fig./Suppl. Fig. 1F). Consistent with this finding was a significant increase in the relative 15 
expression of heme oxygenase 1 (HO-1; p<0.001), known to be induced by hypoxia [27]. In 
contrast, there were no differences in the relative expression of antioxidant enzymes (GPX1, 
GPX4, SOD1, SOD2), or in mitochondrial membrane potential (Fig./Suppl. 1G-H). These 
findings confirmed prior understanding of the effects of hypoxia on hESC renewal, namely 
promotion of growth and pluripotency gene expression [3-5]. They also revealed a positive 20 
correlation between 2OG dioxygenase expression, genomic hydroxymethylation, ROS and a 
ROS responsive gene.  
 
Interference with KDM4C and TET1,2,3 in hESCs 
Given hypoxia-associated elevation in the expression of KDM4C, TET1 and 3, we next 25 
assessed the consequences of interference with these genes. hESC lines were transfected 
with gene-specific small interfering RNA (siRNA) twice at one day (24 hour) intervals one 
day after plating, with cells analysed two days after the first transfection (Suppl. Fig. 15). As 
a negative control to assess general toxicity of the siRNA transfection conditions, cells were 
transfected with an siRNA (IDS-NULL) composed of randomised sequence derived from the 30 
human IDS gene. An siRNA directed against YAP1 was used as an additional control for 
responses to knockdown of an hESC-expressed gene not required for self-renewal, despite 
its role in embryonic cell polarisation and ectodermal lineage specification [28, 29]. As a 
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positive control for an effect on hESC renewal we used an siRNA directed against OCT4. 
Significant reductions in the steady state level of gene transcripts targeted by each siRNA 
were confirmed in both cell lines for YAP1, OCT4, KDM4C, TET1 and TET2 (p<0.05; 
Fig./Suppl. Fig. 2A). Interference with OCT4, KDM4C, TETs1-3 individually and TETs1-3 
together, but not YAP1 or IDS-NULL, disrupted hESC colony morphology and reduced 5 
immunofluorescence for OCT4 and NANOG (Fig./ Suppl. Fig. 2B,C). siRNA targeting of 
OCT4 consistently reduced relative mRNA levels of NANOG and KDM4C, whereas targeting 
YAP1 did not, nor did it affect OCT4, TET1, 2 and 3 (p<0.05; Fig./Suppl. Fig. 2D). By 
contrast, interference with KDM4C consistently reduced mRNA levels of KDM4C itself, 
OCT4, NANOG, TET1 & TET3 (p<0.01). Interference with TET1 consistently reduced levels 10 
of itself, and KDM4C and increased SOX2 (p<0.05). Interference with TET2, TET3 or all 
three TETs together consistently reduced levels of OCT4 and KDM4C (p<0.05) (Fig./Suppl. 
Fig. 2E). 
We next assessed the downstream consequences of RNA interference on genomic 
methylation by qualitative assessment of 5mC and 5hmC by immunocytochemistry, 15 
quantification of the latter by ELISA, and lineage associated gene expression. Interference 
with IDS-NULL and YAP1 had no effect on genomic 5mC or 5hmC, whereas interference 
with OCT4 and all of the 2OG dioxygenases qualitatively and quantitatively (p<0.01) reduced 
5hmC abundance (Fig./Suppl. Fig. 3A,B). To assess whether interference with 2OG 
dioxygenase RNA resulted in differentiated lineage bias, we defined a germinal lineage 20 
marker gene panel consisting of: CDX2, CGα, PL1 (Trophoblast); Brachyury, VEGF, BMP2, 
GATA2 (Mesoderm); GATA4, AFP, ALBUMIN, HNF4α, GATA6 (Endoderm); PAX6, 
NESTIN, TUBULIN-III, NF-200 (Ectoderm); and HAND1 (multiple early lineages) (Fig./Suppl. 
Fig. 3C). Interference with specific 2OG dioxygenases affected specific lineage markers 
consistently, and differed in which lineage panels were affected. The most compelling 25 
evidence of a lineage bias was for ectoderm following knockdown of TET1, as reflected by 
elevation in all four markers (p<0.05). But this was also accompanied by an increase in one 
mesoderm (BMP2) and two endoderm markers (HNF4α, GATA6), with no effect on 
trophoblast markers. Otherwise Interference with KDM4C affected genes across all four 
lineage marker sets, but was confined to an increase in one trophoblast (CGα), one 30 
mesoderm (GATA2), two endoderm (GATA4 and GATA6), and one ectoderm (NESTIN) 
marker (p<0.05). Like TET1, knockdown of TET2 affected 3 lineage marker sets, but this 
time excluding endoderm, and affects were confined to a decrease of one trophoblast 
marker (CGα) and increase of one mesoderm (BMP2) and one ectoderm marker (PAX6) 
(p<0.05). Inhibition of TET3 affected two lineage marker sets: increasing one mesoderm 35 
(BMP2) and one ectoderm (PAX6) marker (p<0.05). Concurrent interference with TET1, 2 
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and 3 affected markers across all four-lineage panels as would be expected, albeit not all of 
the same genes as when specific TETs were targeted. Again, ectoderm markers were the 
most affected (elevations in PAX6, TUBULIN III, NF-200), along with an increase in different 
trophoblast (CDX2) and mesoderm (VEGF, BMP2) markers, a conserved increase in an 
endoderm marker (GATA6), and an increase in a multiple early lineage marker (HAND1) 5 
(p<0.05 to p<0.0001; Fig./Suppl. Fig. 3C). By comparison, interference with OCT4 affected 
genes across 3 lineages, this time excluding mesoderm, but was confined to an increase in 
a trophoblast (CDX2), endoderm (GATA6), and two ectoderm (PAX6 and NESTIN) markers 
(p<0.05).  
 10 
A role for ambient oxygen in modulating chemically-induced oxidative stress response  
Given a positive correlation between hypoxic ambient oxygen, elevation of overall ROS and 
expression of KDM4C, TET1 and 3 in hESCs, and a role for these genes (and TET2) in 
maintenance of hESC renewal, we next investigated the consequences of hESC exposure to 
a low grade chemically-induced oxidative stress under normoxia and hypoxia. To model 15 
oxidative stress originating from organometallic contaminants in cell culture-supportive water 
sources, vessels, materials or gas containers, we established the inhibitory concentration 
range for hESC lines exposed to arsenic in the form of Sodium Arsenite (NaAsO2) under 
continuous culture for 7 days under normoxia. NaAsO2 is known to affect cellular redox 
states, antioxidant defence systems and epigenetic determinants in other cells [18, 29, 30]. 20 
Determination of the inhibitory concentration at which we observed a 10% reduction in cell 
viability (IC10) revealed that this differed widely between lines (H9, 1x10-9 M; RH1, 3.3x10-11 
M, Suppl. Fig. 12). For both lines, exposure to the cell line-specific IC10 consistently resulted 
in loss of hESC colony morphology, correlated with qualitative loss of OCT4 and NANOG 
immunofluorescence under normoxia but not hypoxia (Fig./Suppl. Fig. 4A,B). Concurrent 25 
treatment with the antioxidant N-acetyl-L-cysteine, NAC, prevented loss of OCT4 and 
NANOG at normoxia and had no effects under hypoxia (Suppl. Fig. 8A,B). Comparison of 
mRNA steady state  levels under each oxygen atmosphere revealed a consistent and 
significant (p<0.0001) elevation of OCT4, NANOG, SOX2, KDM4C, TET1 and TET2 in 
NaAsO2-treated cells under hypoxia (relative to untreated), whereas these genes and TET3 30 
were either significantly reduced or unchanged as a result of treatment in normoxia (p<0.01; 
Fig./Suppl. Fig. 4C). Co-administration with NAC significantly elevated OCT4, KDM4C, TET1 
and TET3 in normoxia (p<0.01), and decreased OCT4, KDM4C and TET2 in hypoxia (Suppl. 
Fig 9A). NaAsO2 induction of differentiation under normoxia was confirmed by a significant 
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increase in relative mRNA abundance for BRACHYURY (p<0.01; Fig./Suppl. Fig. 4D). This 
was significantly reduced by co-administration of NAC (p<0.0001; Suppl. Fig. 9B). By 
immunofluorescence microscopy NaAsO2 treatment under normoxia resulted in a loss of 
5mC, consistent with previous reports of its inhibition of DNA methyltransferases [30, 31]. 
This was not evident under hypoxia (Fig./Suppl. Fig. 4B). Co-administration of NAC 5 
preserved 5mC fluorescence under normoxia and had no effect on 5mC under hypoxia or 
5hmC under normoxia or hypoxia (Suppl. Fig. 8AB). There was no obvious effect of NaAsO2 
on 5hmC immunofluorescence in either atmosphere, except for regions of cell differentiation 
reflected by greater spacing between cells that corresponded with loss of 5mC where it 
appeared qualitatively brighter under normoxia, (Fig./Suppl. Fig. 4B). As whole mount 10 
fluorescence imaging was not confocal we did not attempt to quantify signal intensity as 
variations could reflect either or both changes in abundance or concentration/diffusion of 
signal. However, quantification of global 5hmC by ELISA revealed a significant decrease 
with exposure to NaAsO2 under normoxia (p<0.001), but an increase if exposed under 
hypoxia (Fig./Suppl. Fig. 4E). Hypoxia significantly elevated global 5hmC relative to 15 
normoxia in the absence of NaAsO2 as observed previously. Co-administration of NAC with 
NaAsO2 significantly elevated 5hmC relative to NaASO2 -treated cells under normoxia only 
(p<0.0001;Suppl. Fig. 9C). Thus, the differentiation-inducing effects of NaAsO2 under 
normoxia could be prevented by antioxidant treatment, which is obviated by hypoxia. 
We next assessed ROS in NaAsO2-treated cells under normoxia and hypoxia and included 20 
hESCs treated with Buthionine Sulfoximine (BSO), known to elevate ROS (Ji et al., 2010). 
ROS were significantly elevated in untreated, NaAsO2- and BSO-treated cells under hypoxia 
relative to normoxia after 1 and 7 days of treatment (p<0.05   Fig./Suppl. Fig. 5A). ROS in 
NaAsO2 and BSO treatment groups were significantly higher than untreated cells in hypoxia 
after 7 days (p< 0.001) and was reduced by co-treatment with NAC (Suppl. Fig. 10A). 25 
NaAsO2-induced ROS elevation under hypoxia was matched by a significant increase in the 
levels of mRNA for hypoxia-inducible HO-1 (p<0.001), a measure of oxidative stress, but not 
the antioxidant genes GPX1, GPX4, SOD1 and SOD2. Levels of the latter four antioxidant 
transcripts were decreased in both lines treated with NaAsO2 under normoxia only (p<0.01; 
Fig./Suppl. Fig. 5B). Co-administration of NAC significantly elevated HO-1 and the 30 
antioxidant genes GPX1 and SOD2 mRNA under normoxia and GPX1 and SOD1 under 
hypoxia, relative to untreated in each atmosphere (Suppl. Fig. 10B). Under both normoxia 
and hypoxia treatment with NaAsO2 significantly reduced the mitochondrial membrane 
potential (MMP) relative to untreated cells (p<0.001, Fig./Suppl. Fig. 5C). Addition of NAC 
improved MMP slightly under both oxygen concentrations although it remained significantly 35 
lower in treated vs untreated cells (p<0.001; Fig./Suppl. 10C, 11B). Thus, under hypoxia, 
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protection against NaAsO2-induced differentiation and loss of hydroxymethylation correlates 
with hypoxia-induced elevation of ROS and HO-1 mRNA levels; however hypoxia does not 
protect against NaAsO2-induced loss of mitochondrial membrane potential.  
 
A role for KDM4C and TETs in modulating oxidative stress response  5 
To investigate the functional significance of KDM4C and TET1 elevation in hypoxia, and to 
test if the expression of these alone could protect against the differentiation-inducing effect 
of NaAsO2 treatment under normoxia, hESC lines were transfected one day after plating with 
episomal plasmid expression vectors encoding KDM4C (pCXLE-KDM4C), TET1 (pCXLE-
TET1), or enhanced Green Fluorescent Protein (pCXLE-eGFP) or no plasmid but exposed 10 
to transfection reagent (RNAiMAX Lipofectamine), the latter two conditions serving as 
negative controls. The transfection efficiency in these experiments was estimated to be 70  
% based on transfection with EGFP expressing plasmid (data not shown). This was followed 
3 days later by exposure to IC10 concentrations of NaAsO2 (or not) for 7 days. In both lines, 
colony morphology and immunofluorescence for NANOG, and 5hmC  were lost by NaAsO2-15 
treated hESCs not transfected with plasmid or transfected with pCXLE-eGFP, whereas 
transfection with pCXLE-KDM4C or pCXLE-TET1 was protective (Fig. /Suppl. Fig. 6A,B). 
NaAsO2 induced loss of 5hmC immunofluorescence was not previously observed in earlier 
experiments, and we speculate that exposure to transfection reagent in these experiments 
may have facilitated permeability and increasing of effective concentration of NaAsO2 and 20 
its consequent effects as has been reported in other cells [32]. Cell transfection with pCXLE-
eGFP and post-fixation and permeabilisation in some cells precluded interpretation of 
microscopic imaging of OCT4 and 5mC immunolabelled with fluorescein in these 
experiments. RT-qPCR confirmed significant decreases in OCT4, NANOG, SOX2, KDM4C 
and TET1 in NaAsO2-treated untransfected or pCXLE-eGFP transfected cells which 25 
transfection with either 2OG dioxygenase protected against (p<0.05; Fig./Suppl. Fig. 6C,D). 
Quantification of 5hmC by ELISA confirmed significant decreases induced by NaAsO2, and 
the protective effects of pCXLE-KDM4C and TET1 but not eGFP (p<0.05; Fig./Suppl. Fig. 
7B,C). Assessment of a limited lineage marker panel consisting of CDX2, BRACHYURY, 
AFP and PAX6 revealed a conserved increase in CDX2 associated with NaAsO2 treatment 30 
alone (p<0.0001), or BRACHYURY with p-eGFP transfected NaAsO2 treated cells. However, 
transfection of NaAsO2-treated cells with pCXLE-KDM4C or pCXLE-TET1 was associated 
with significantly lower BRACHYURY (p<0.05) and unchanged levels of CDX2 and other 
lineage-associated transcripts (Fig./Suppl. Fig. 7D). Thus, transient expression of either 2OG 
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dioxygenase alone was sufficient to mimic the protective effect of hypoxia against NaAsO2 
induced differentiation.  
 
Discussion 
We investigated the possible role for the 2OG dioxygenases KDM4C and TETs as oxygen 5 
sensors to mediate the known benefits of hypoxia in support of hESC renewal. We observed 
that previously reported benefits of hypoxia including promotion of hESC growth and up-
regulation of pluripotency-associated transcription factors are accompanied by elevation of 
ROS, expression of a hypoxia-induced heme-oxygenase, KDM4C and TETs, and global 
genomic 5hMC. Furthermore, siRNA targeting of KDM4C and TET1-3 induced loss of 5hmC 10 
and hESC differentiation. We also observed distinctions between the consequences of 
hESC exposure to chemically-induced vs hypoxic ambient atmosphere-induced oxidative 
stress, which involved these dioxygenases. Specifically, under normoxia subcytotoxic 
exposure to the organometallic compound and known chemical oxidative stressor, NaAsO2, 
induces loss of 5mC and 5hmC and differentiation, whereas treatment with this compound 15 
under hypoxia or ectopic expression of KDM4C or TET1 protects against these effects. 
Collectively our study substantiates the sufficiency of dioxygenases to protect against 
chemical oxidative stress-induced differentiation and as a mechanism by which hypoxia 
promotes pluripotency. 
Several studies have confirmed the benefits of lower ambient oxygen concentrations than 20 
are present in the atmosphere (21% O2) for renewal or induction of pluripotency [4, 6, 7, 9, 
33, 34] . Oxygen-sensing 2OG dioxygenases such as TET1 and histone lysine-specific 
demethylases have been implicated in pluripotency renewal [11, 13-16]. However, to our 
knowledge the sufficiency of 2OG dioxygenases to mediate the benefits of hypoxia in 
pluripotent stem cells has not been shown. In other cell systems both TET1 and KDM4C 25 
have been shown to facilitate/co-activate hypoxia-inducible factor expression, and in turn, to 
be regulated by them [13, 35-46]. It has also been proposed that the induction of Jumonji 
domain-containing histone demethylases under low oxygen conditions provides a 
compensatory mechanism in response to compromised oxygen availability [42]. Our work is 
consistent with this model and previous studies in other cell types showing that hypoxia 30 
induces the transcriptional upregulation of 2OG-dioxygenases KDM4C and TET1. For 
example, in breast cancer cell lines cultivated in 0.5% O2, HIF-1 binds to the promoters of 
dioxygenases generally, and KDM4C specifically, and the expression of these dioxygenases 
is upregulated. KDM4C specifically catalyses the demethylation of H3K36 [47]. Upregulation 
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of KDM4C has also been shown previously in hESCs in response to a less hypoxic 
atmosphere than we used in our study (5% O2), along with OCT4, NANOG and SOX2 [48]. 
Hypoxia-induced HIF-1-dependent upregulation of TET1 expression in association with 
upregulation of canonical hypoxia-responsive genes and genomic 5hmC levels have been 
demonstrated in neuroblastoma cells [45]. Putative HIF-1a binding sites have been identified 5 
in the promoters of TET1 and 3, but not TET2 [15], consistent with our observations of a 
differential response to hypoxia in the relative abundance of mRNA encoding these proteins.  
Our targeted interference with KDM4C and TET1-3 resulted in loss of hESC self-renewal 
and genome hydroxymethylation in both cell lines for all 2OG dioxygenases. Perturbations in 
the mRNA steady state level of individual dioxygenases also appeared to affect others 10 
differentially. In both lines, we observed that targeting each of KDM4C, TET1 and 3 reduced 
the level of the others and that these effects were reciprocal. In contrast, targeting TET2 only 
reduced KDM4C. These results substantiate all of the dioxygenases in our study forming 
part of the pluripotency gene network. This is further supported by interrogation of the 
StemCellNet network analysis platform (http://stemcellnet.sysbiolab.eu; [49]), an interactive 15 
platform for retrieval and analysis of molecular networks associated with pluripotent stem 
cells. Based on the studies informing this database, all dioxygenases physically interact or 
are transcriptionally regulated by a minimum of 3 (TET3) and as many as 26 (KDM4C) 
stemness associated genes. OCT4, NANOG and SOX2 all directly regulate KDM4C and 
TET2. OCT4 and NANOG also physically interact with TET1[50]. Further, the transcription 20 
factors SMAD2 and 3, downstream of TGF-b/activin type 1 receptor signal transduction, 
regulate TET1, TET3 and KDM4C (Suppl. Fig. 17).  
 
Assessment of gene interference-induced differentiation using a finite gene marker panel for 
germinal lineage representation was made difficult by gene marker specific variations, 25 
however, interference with TET1 appeared to bias differentiation towards ectoderm in both 
cell lines. The opposite trend towards mesendoderm differentiation was observed after 
KDM4C knockdown with the H9 cell line alone. The possibility that this could reflect different 
lineage potency bias between cell lines cannot be ruled out. However, this was not grossly 
evident in qualitative in vitro (embryoid body) and in vivo (teratoma) assessments by our 30 
group ([25], data not shown). The first report of the consequences of transient silencing of 
histone-H3 Lysine specific demethylases including KDM4C (JMJD2C) was inconclusive on 
the nature of differentiation following loss of pluripotency [13]. In mouse ESC clones stably 
expressing a short-hairpin RNA to TET1, evidence of genomic hydroxymethylation is 
accompanied by skewing of lineage potential to mesendodermal and extraembryonic 35 
lineages, not ectoderm [51]. Mouse gene knockout studies suggest double knockout of TET1 
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and 2, resulting in complete depletion of genome hydroxymethylation does not result in cell 
differentiation. Further, although the absence of 5hmC and both TETs induces 
developmental abnormalities and midgestation and perinatal death, overtly normal 
development can still occur. [52]. We speculate that divergence of outcomes between our 
and these studies reflect differences in both experimental method and the response potential 5 
of both naïve vs primed states of pluripotency between mouse and human cells, with the 
comparatively hypomethylated genome in a naïve state defining a lower dependence on 
2OG dioxygenase activity to mediate ambient oxygen/reactive oxygen species mediated 
differentiation induction. Additionally, during development, other compensatory mechanisms 
exist. 10 
 
Our study used subcytotoxic exposure to NaAsO2 to achieve a chemically induced oxidative 
stress. In other cell types, both acute and chronic exposure to NaAsO2 at low concentrations 
(0.5 - 5µM; still 2-4 fold greater than used here) inhibit DNA methyltransferase enzymes 
(DNMTs), deplete the S-adenosylmethionine (SAM) pool and result in genomic DNA 15 
hypomethylation [31]. At high doses (> 5 µM) it is a general cell poison acting as a sulfhydryl 
reagent binding to the free thiol groups of enzymes, inhibiting their function and depleting 
glutathione that destroys cell metabolism. [30, 53]. At low and high doses, reactive oxygen 
species which it generates induce mitochondrial damage, DNA mutagenesis and apoptosis 
[17, 19-21].   In vivo, it is a transplacental acting teratogen which interferes with neural 20 
development [30]. In vitro studies in mouse embryo stem and carcinoma cell lines report its 
capacity to inhibit stem cell renewal and embryoid body-mediated or neural stem cell 
differentiation via suppression of PI3K-AKT and B-catenin and overactivation of MEK-ERK 
signal transduction pathways [54-56]. ERK activation is necessary for mesoderm 
differentiation, and reactive oxygen species enhance differentiation into the mesendodermal 25 
lineage[57-59]. Although our study did not attempt to characterise differentiation induced by 
NaAsO2 under normoxia, elevation of the mesodermal marker Brachyury aligns with these 
findings.  
 
Supplementation of culture media with substances with antioxidant activity (e.g. NAC, or 30 
more commonly ß-mercaptoethanol, dithiothreitol, glutathione, lipoic acid, or Vitamins [C, E]) 
is a standard approach to counter ROS production in culture. But, the presence of these in 
the media systems used in these experiments were still insufficient to counter ROS 
produced by subcytotoxic NaAsO2 exposure. For this, the hypoxia induced molecular 
responses, evidenced in our study by elevation of HO-1 expression, are necessary, or  more 35 
specifically the elevation of 2OG dioxygenase expression downstream of this response, as 
we demonstrate. Hypoxia’s ability to block NaAsO2 induction of differentiation occurred 
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despite its own induction of ROS, and further reduction of mitochondrial membrane potential. 
Our study intentionally utilised a generic fluorescence-based ROS reporter (2’, 7’-
dichlorofluorescein diacetate; DCF-DA) in the first instance which as a consequence 
precluded discrimination of the origin of reactive oxygen species (i.e. O2-, OH•, NO2• and 
ONOO-). This requires investigation in  future studies. Both hypoxia and NaAsO2 are likely to 5 
elicit ROS by different mechanisms, with our study observing a difference at the level of HO-
1 induction at least at the single time points assessed. Our study used low inhibitory IC10 
exposures (empirically determined for each cell line) as a model for chemical contamination 
which could derive from water or vessels used in tissue culture. Importantly, these IC10 
values were at least 2-4 orders of magnitude lower than World Health Organisation 10 
Guidelines for naturally-occurring chemicals that are of health significance in drinking water 
(10 parts per billion, for NaAsO2, equating to 0.77 x10-7 M; WHO, 2011). Water quality in cell 
culture has long been understood to be an important issue, yet certificates of analyses that 
accompany commercially-supplied media do not normally qualify chemical contaminant 
levels. To our knowledge there have been no published investigations of arsenic as a 15 
contaminant in routine cell culture materials or vessels. It is interesting to ponder the extent 
to which variation encountered in the ability to maintain undifferentiated pluripotent stem 
cells across cell lines in different laboratories and with different reagents might be affected 
by subcytotoxic contamination of cultures with organometallic compounds such as arsenic. 
We suggest in the light of our data that an additional benefit of culturing pluripotent stem 20 
cells in hypoxic atmosphere is protection against such influences and furthermore, that the 
certification of reagents for pluripotent stem cell culture should include levels of trace 
organometallic compounds.  
 
In conclusion, our study furthers understanding of the known benefits of hypoxia to promote 25 
undifferentiated pluripotent hESC growth by demonstrating a role for oxygen-sensing 
dioxygenases, specifically KDM4C and TET1, which alone can protect against differentiation 
induced by chemical oxidative stress. This supports implementation of hypoxia as best 
practice in the culture of human pluripotent cells.  
 30 
 
Experimental Procedures 
 
Cell culture of hESCs 
 35 
Experiments were performed on RH1 [25] and H9 [24] hESC lines derived from 
cryopreserved stocks cultured under feeder-free conditions, in a human dermal fibroblast-
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conditioned medium supplemented with 4 ng/ml of human basic fibroblast growth factor 
(Peprotech), nutrients and 20% Knockout serum replacement (HDF-CM+). Cells were plated 
on Matrigel (BD Biosciences)-coated plates under a humidified atmosphere of 5% CO2 in air 
(21% O2) at 37oC, as described previously [25]. Unless otherwise stated, experiments were 
performed on cell lines transitioned for at least 5 passages into mTeSR1 (StemCell 5 
Technologies) on Matrigel, and used within a recorded feeder-free passage number range 
between p45 and 70. For hypoxic induction, hESCs were cultured in a multi-gas incubator 
where nitrogen gas was supplied to maintain the controlled reduced percentage of 0.5% O2. 
For hypoxic cultures, cell culture media and PBS were all incubated in the hypoxic 
atmosphere overnight prior to every medium change in order to minimize the exposure of 10 
cells to atmospheric oxygen levels (21% O2). Medium changes were performed every two 
days and the process was performed within two minutes in order to reduce exposure to 
atmospheric oxygen as much as possible, unless otherwise stated. For each ambient 
atmosphere hESC lines were seeded in triplicate cultures for each time point to be 
harvested, in a 6-well plate format (20,000 per cm2). Cells were harvested at each time point 15 
for cell counting. Cell numbers were determined using a haemocytometer to count 0.01% 
Trypsin-EDTA- passaged single cell suspensions. 
 
 
Subcytotoxic treatment of compounds on undifferentiated hESCs 20 
 
NaAsO2 concentration treatment cytotoxic range finding for each cell line was performed first 
using undifferentiated hESCs cultured with HDF-CM+ culture medium. At day 0, hESCs 
were seeded in triplicate cultures for each concentration at a density of 1x104 cells/well in 
96-well tissue culture plates in 0.1 ml of HDF-CM+ medium and then cultivated for 24 hours 25 
at 5% CO2 in humidified air at 37oC. The following day, the culture medium was withdrawn 
and replaced with medium containing a specified concentration of NaAsO2. Over 7 days of 
treatment, cultivation media were refreshed every 48 hours. At the endpoint of culture viable 
cell numbers were assessed with the CellTiter-Blue Cell Viability Assay (Promega) according 
to manufacturer’s instructions with each well being measured at 560 nm using a POLARstar 30 
Optima microplate reader (BMG LABTECH). Cytotoxic range profiles for each cell line were 
independently confirmed in feeder-free mTESR-1/Matrigel culture conditions (data not 
shown). For experiments evaluating NaAsO2 at line-specific IC10 treatment concentrations, 
hESC lines were seeded at 5x104 cells/well in HDF-CM+/Matrigel-coated 12-well plates for 
24 hours prior to treatment. Treatments were for 7 days with media refreshed every two days 35 
as for cytotoxicity range finder experiments.  
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Determination of reactive oxygen species (ROS) production 
 
The generation of ROS in hESC cultures was evaluated using the fluorescent dye 2’, 7’-
dichlorofluorescein diacetate (DCF-DA; 2 µM). Briefly, hESC were seeded in 6-well Matrigel-5 
coated plates and exposed to a normoxia/hypoxia atmosphere with or without NaAsO2 for 
one or seven days. Harvested cells were DCF-DA treated (control + dye) or not (control – 
dye) in PBS for 40 min in a 37oC water bath in darkness. Following incubation, the 
fluorescence was measured using a FACSCalibur (BD Biosciences) flow cytometer. The 
brightness of the fluorescence is considered to reflect the extent to which ROS are present 10 
[60, 61]. Fluorescence intensity of at least 1x104 cells was measured for each sample and 
experiments performed in quadruplicate. Data were analysed using the FCS Express 4 
Image Cytometry software (De Novo Software). 
 
 15 
Determination of mitochondrial membrane potential (MMP)  
 
The mitochondrial membrane potential in hESCs was measured using Rhodamine 123. 
Briefly, cells were cultured in 96-well plates and treated with NaAsO2 under normoxic (21% 
O2) and hypoxic (0.5% O2) atmospheres for seven days. At day 7, cells were washed once 20 
with PBS and incubated with Rhodamine 123 (2 µM) for 40 min at 37oC in darkness. 
Following incubation, the fluorescence was quantified using a POLARstar Optima microplate 
reader. The fluorescence intensity was measured for quadruplicate biological samples and 
experiments performed in triplicate for each human ESC line.  
 25 
 
RNA isolation, reverse transcription and quantitative real-time PCR analysis 
 
Total RNA isolation was performed using TRIzol Reagent (Life Technologies), according to 
the manufacturer’s protocol. CDNA was synthesized using the SuperScript III First-Strand 30 
Synthesis System for RT-PCR Kit (ThermoFisher Scientific) according to the manufacturer’s 
instructions using oligo(dT) primers.  Quantitative RT-PCR (RT-qPCR) fo r  e ach  gene 
t ran scr ip t  in  ea ch  biological replicate was executed in triplicate using the  DyNAmo 
Flash SYBR Green qPCR Kit (ThermoFisher Scientific) and reactions were amplified with a 
StepOne Plus thermocycler (Applied Biosystems). A standard thermocycling protocol was 35 
applied for all genes consisting of: 1) initial denaturation for 7 min at 95oC; 2) Denaturation 
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for 10 sec at 95oC; 3) Annealing/extension for 30 sec at 58-60oC; 4) 40 cycles of steps 2 and 
3; and 5) a melting curve lasting 25 sec over a temperature range of 65 to 95oC. Triplicate 
reactions were assessed to determine the cycle threshold (Ct) value for a given transcript. If 
data from the parallel reactions varied more than 0.5 cycles, the reactions were repeated or 
excluded from the data analysis. The Ct values of the target genes were normalised against 5 
those of the housekeeping genes GAPDH or β-ACTIN, depending on experimental 
conditions. GAPDH was used in siRNA experiments and β-ACTIN in all experiments where 
atmospheric oxygen was a variable experimental parameter given the oxygen dependence 
of the former. In the event of comparison of outcomes between atmospheric atmospheres, 
results are expressed as fold change relative to normoxia. Oligonucleotide primer sequences 10 
are tabulated in Suppl. Fig.14, and reported previously [12, 62, 63].  
 
Immunocytochemistry 
 
Indirect immunofluorescence for OCT4, NANOG, 5mC and 5hmC were performed as 15 
previously described in  and references therein. Primary and secondary antibody suppliers 
and dilutions are provided in Suppl. Fig. 13. Nuclei were labelled with DAPI. Images were 
captured using a Zeiss Observer fluorescence microscope and prepared using Zeiss 
AxioVision 4.8.2 software.  
 20 
 
Enzyme-linked immunosorbent assay (ELISA) of global DNA 5hmC content 
 
The 5hmC content of extracted genomic DNA from untreated and treated hESCs was 
measured using a hydroxymethylated DNA quantification kit (Quest 5hmC DNA ELISA Kit, 25 
ZYMO Research) according to manufacturer’s protocol. The quantification of the 5-hmC was 
performed by reading the absorbance at 450 nm in a POLARstar OPTIMA microplate 
reader. The percentage of 5hmC in samples was calculated based on a standard curve 
generated according to the manufacturer’s instructions. A minimum of quadruplicate 
biological replicates were run unless indicated otherwise.  30 
 
 
Small Interfering RNA (siRNA) knockdown  
 
Quadruplicate cultures of hESCs in mTESR-1 on Matrigel were transfected with target-35 
specific siRNA twice at 24 hours intervals, 48 hours and 72 hours after plating (Suppl. Fig. 
15). Targeted genes included KDM4C, TET1, TET2, TET3, all 3 TETs concurrently, OCT4 
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and YAP1 (reference genes required and not required for hESC renewal, respectively [12, 
64]). As a further control for non-specific effects of siRNA transfection, hESCs also were 
transfected with a mutated sequence based on the human IDS gene (IDS-NULL) which 
targets no sequence in the human genome, against which effects on gene expression could 
also be normalised. To assess targeted siRNA effects on gene expression, transcript-5 
specific mRNA first normalised internally to GAPDH values for each siRNA treated cell 
sample, were then calculated as fold differences relative to IDS-NULL-treated samples. 
siRNAs were transfected into hESCs using RNAiMAX Lipofectamine (Invitrogen) according 
to manufacturer’s instructions. SiRNA sequences target specificity was checked using 
SpliceCenter [65]. Gene targeted siRNA sequences were as follows: IDS-NULL, 10 
GGCGACACCACCUAACAUU; YAP1, UCACAUCGAUCAGACAACA; OCT4, 
AUCUUCAGGAGAUAUGCAA; KDM4C, GUACAUCUGUAACAGAAGA; TET1, 
ACUCUGAAGUUGACAAG; TET2, CAAGACCAAUGUCAGAA; TET3, 
GAUGAAGGUCCAUAUUA. Cells were harvested for analysis 24 hrs after the second siRNA 
transfection.  15 
 
 
Nucleofection of hESCs with expression plasmids  
  
HESCs were harvested by trypsinization. They were then transfected with episomal 20 
plasmids by nucleofection of 4x105 cells with 0.29 μg DNA in a 20 μl reaction using 
nucleofection solution P2 and program EN-150 and running on a 4D-Nucleofector system 
(Lonza). Following transfection, cells were quickly transferred into Matrigel -coated 6-well 
plates containing pre-warmed mTeSR1 medium. Episomal plasmids and their preparation for 
nucleofection were as reported previously ([12]; Suppl. Fig.16).  25 
 
 
Statistical analysis  
 
Statistical analyses were performed using GraphPad Prism software version 5 for Windows 30 
(GraphPad Software, San Diego, California USA). Values are expressed as the mean ± 
standard deviation (SD) throughout. Differences between the various conditions were 
assessed by unpaired t-test or one-way ANOVA with Dunnett’s post-test, as appropriate, 
unless otherwise specified.  
 35 
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StemCelNet Network Analysis 
 
To identify prospective molecular interactions between dioxygenases in our study with 
pluripotency and non-pluripotency associated genes we interrogated StemCellNet 
(http://stemcellnet.sysbiolab.eu; [49]). The StemCellNet database includes  i) 11 5 
independently published mouse and human embryonic stem cell gene expression studies; ii) 
, physical protein interactions in murine embryonic stem cells identified using affinity 
purification and mass spectrometry to identify targets in seven studies whose targets 
included pluripotency associated transcription factors (ie. example OCT4-POU5F1, NANOG, 
SOX2); iii) transcriptional regulatory interactions by chromatin immunoprecipitation combined 10 
with microarray and sequencing technologies in 18 studies targeting the pluripotency 
associated transcription factors; iv) physical and regulatory interactions from the Unified 
Human interactome data. The last incorporates data from 15 primary sources (MDC-Y2H, 
CCSB, HPRD, BioGRID, BIND, DIP, IntACT, Reactome, COCIT, ORTHO, HOMOMINT, 
OPHID, TRANSFAC-public version, miRTarBase, HRRIdb). The StemCellNet database 15 
defines stemness gene sets from i-iii) of the aforementioned resources and scale functional 
RNAi screens to detect genes whose knock-down leads to loss of stem cell markers. 
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Figure Legends 
 
Figure 1. Effect of hypoxia versus normoxia on measures of hESC phenotype, 10 
dioxygenase expression and function and oxidative stress as assessed in H9 hESCs. 
(A) Compacted colony morphologies observed following 7 days of feeder-free cultivation 
under normoxia (21% O2) vs hypoxia (0.5% O2). Bar equals 100 µm. (B) Hypoxia enhances 
hESC growth over 7 days of cultivation. Bars depict the mean fold increase from day of 
seeding ± SD to each time for each atmosphere (Seeding Density 20,000/cm2; n=3). (C) 15 
Representative immunocytochemical detection of OCT4, NANOG, 5mC, 5hmC and 
fluorescent staining of nuclear DNA (DAPI) after 7 days of culture. Bar equals 100 µm. (D) 
ELISA quantification of 5hmC after 7 days of culture. Bar depicts mean ± SD (n=3). (E) Log10 
fold change in steady state level of mRNA for pluripotency genes (OCT4, NANOG and 
SOX2) and dioxygenases (KDM4C, TET1, TET2 and TET3) after 7 days in hypoxia relative 20 
to normoxia, set as 1 (n=4) (F) Generation of ROS at days 1 (D1) and 7 (D7) of culture 
under normoxia vs hypoxia assessed by flow cytometry detection of DCF dye fluorescence 
emission from stained (CTRL + dye) and unstained cells (CTRL - dye). Bars depict mean 
values ± SD of n= 6 (D1) and 7 (D7). (G) Hypoxia elevates steady state level of mRNA for 
HO-1 but not GPX1, GPX4, SOD1 and SOD2 assessed at 7 days of culture. Log10 fold 25 
increase in hypoxia treated cells relative to normoxia, set as 1 (n=4). (H) Mitochondrial 
membrane potential did not vary between cells cultured under both atmospheres for 7 days, 
as assessed by Rhodamine 123 fluorescence intensity. Bars represent mean fluorescence 
intensity ± SD (n=3). Conserved outcomes between cell lines (▼). Asterisks denote level of 
significance for representative outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; 30 
****p<0.0001). 
 
 
 
 35 
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Figure 2. RNA interference targeting OCT4, KDM4C and TET1/2/3 perturbs 
morphological and molecular measures of pluripotency as assessed in H9 hESCs. (A) 
Log10 fold change in steady state mRNA level of the siRNA targeted genes (YAP1, OCT4, 
KDM4C, TET1, TET2, TET3 and TET1-3 concurrently) expressed relative to cells 
transfected with random sequence derived from human IDS gene (IDS-NULL)  (n=4). (B) 5 
Representative colony morphology corresponding to aforementioned siRNA transfections. 
Transfection with YAP1 and IDS-NULL siRNA have no effect on colony morphology, 
whereas targeting of OCT4, KDM4C and TET1-3 does. Bar equals 100 µm. (C) 
Immunocytochemistry for OCT4 and NANOG corresponding to aforementioned 
transfections. Transfection with YAP1 and IDS-NULL siRNA have no qualitative effect on 10 
immunostaining for pluripotency markers whereas targeting of OCT4, KDM4C, TET1-3 does. 
Bar equals 100 µm. (D) Log10 fold change in state levels of mRNAs for pluripotency 
associated transcription factors (OCT4, NANOG, SOX2) and dioxygenases (KDM4C, 
TET1,2,3 and TET1-3 inclusive) following siRNA targeting of YAP1 and OCT4 as above 
(n=4). Only targeting OCT4 results in significant changes in pluripotency or dioxygenase 15 
gene transcription. (E) Log10 fold change in state levels of mRNAs for pluripotency 
associated transcription factors (OCT4, NANOG, SOX2) and dioxygenases (KDM4C, 
TET1,2,3 and TET1-3) following siRNA targeting of dioxygenases (n=4). Consistent with 
effects on morphology and OCT4 and NANOG immunocytochemistry, targeting all 
dioxygenases generally results in significant lowering of OCT4, NANOG and other 20 
dioxygenases. Conserved outcomes between cell lines (▼). Asterisks denote level of 
significance for representative outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001). 
 
 25 
Figure 3. RNA interference targeting KDM4C and TET1/2/3 in H9 hESCs lowers 
genomic 5hmC content and induces differentiation associated alterations in lineage 
marker expression. (A) Representative immunocytochemical detection of 5mC and 5hmC 
and fluorescent labelling of nuclear DNA (DAPI) following transfection with siRNAs directed 
against IDS-NULL, YAP1, OCT4, KDM4C, TET1, TET2, TET3 and TET1-3. Bar equals 100 30 
µm. (B) ELISA quantification of 5hmC in siRNA treated cells. Bars represent mean 
percentage of genomic DNA +/- SD (n=3). (C) Log10 fold change after siRNA treatments 
expressed relative to cells transfected with random sequence derived from human IDS gene 
(IDS-NULL), set as 1 (n=4). Conserved outcomes between cell lines (▼). Asterisks denote 
level of significance for representative outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; 35 
****p<0.0001). 
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Figure 4. Differential effects of NaAsO2 under normoxia vs hypoxia on measures of 
hESC phenotype and dioxygenase expression and function as assessed in H9 hESCs. 
(A) NaAsO2 disrupts undifferentiated colony morphology under normoxia but not hypoxia. 
Bar equals 100 µm. (B) Representative immunofluorescent staining for OCT4, NANOG, 5 
5mC, 5hmC and nuclear DNA (DAPI) following treatment with NaAsO2 or not under 
normoxia or hypoxia. Bar equals 100 µm. (C) Log10 fold change in levels of mRNA for OCT4, 
NANOG, SOX2, KDM4C, TET1, TET2 and TET3 following treatment with NaAsO2 under 
normoxia or hypoxia expressed relative to untreated cells in the same atmosphere, set as 1 
(n=4). (D) Log10 fold change in levels of mRNA for germinal lineage markers CDX2, 10 
BRACHYURY, AFP and PAX6 under normoxia following treatment with NaAsO2 expressed 
relative to untreated cells set as 1 (n=4). (E) ELISA quantification of 5-hmC in NaAsO2 
treated and untreated cells in normoxia vs hypoxia. Bars equal mean + SD (n=3). Conserved 
outcomes between cell lines (▼). Asterisks denote level of significance for representative 
outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 15 
 
 
Figure 5. Differential effects of NaAsO2 under normoxia vs hypoxia evident in 
measures of oxidative stress as assessed in H9 hESCs. (A) Generation of ROS at days 
1 (D1) and 7 (D7) of culture following treatment or not with NaAsO2 under normoxia vs 20 
hypoxia. ROS were determined by flow cytometry detection of DCF dye fluorescence 
emission from stained (CTRL + dye) and unstained cells (CTRL - dye) cells. Buthionine 
Sulfoximine (BSO) is known to elevate ROS. Bars depict mean values ± SD of n= 6 (D1) and 
7 (D7). (B) Log10 fold change in levels of mRNA for HO-1 and antioxidants GPX1, GPX4, 
SOD1, SOD2 in NaAsO2 treated cells under normoxia vs hypoxia expressed relative to 25 
untreated cells, set as 1 (n=4). (C) Mitochondrial membrane potential in NaAsO2 treated and 
untreated control cells under normoxia or hypoxia. Bars represent mean Rhodamine 123 
fluorescence intensity ± SD (n=4). Conserved outcomes between cell lines (▼). Asterisks 
denote level of significance for representative outcomes for H9 (*p<0.05; **p<0.01; 
***p<0.001; ****p<0.0001). 30 
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Figure 6. Transfection with plasmids encoding KDM4C or TET1 protects against 
NaAsO2 induced differentiation under normoxia as assessed in H9 hESCs. (A) 
Compacted colony morphology is protected by transfection with plasmids (pCXLE-) 
encoding KDM4C and TET1 but not eGFP, or exposed to transfection reagents only prior to 
treatment with NaAsO2 under normoxia. Bar equals 100 µm. (B) Immunofluorescent staining 5 
for OCT4 and NANOG correlate with aforementioned effects on colony morphology. Bar 
equals 100 µm. Corresponding cell nuclei depicted by DAPI staining. (C) Log10 fold change 
in mRNA for OCT4, NANOG, SOX2 in aforementioned treatment groups depicted relative to 
untreated control (no plasmid) set as 1 (n=4). (D) Log10 fold change in mRNA for KDM4C, 
TET1, TET2 and TET3 in aforementioned treatment groups. Gene transcript levels are 10 
internally normalised to GAPDH and depicted relative to untreated control (no plasmid) set 
as 1 (n=4). Conserved outcomes between cell lines (▼). Asterisks denote level of 
significance for representative outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001). 
 15 
 
Figure 7. Transfection with plasmids encoding KDM4C or TET1 promotes genomic 
5hmC content and inhibits differentiated lineage marker expression despite treatment 
with NaAsO2 under normoxia as assessed in H9 hESCs. (A) Immunofluorescent staining 
for 5mC and 5hmC correlate with aforementioned effects on colony morphology. Bar equals 20 
100 µm. Corresponding cell nuclei depicted by DAPI staining. (B) ELISA quantification of 
5hmC in pCXLE-KDM4C transfection experiment. Bars represent mean + SD (n=3). (C) 
ELISA quantification of 5-hmC in pCXLE-TET1 transfection experiment. Bars represent 
mean + SD (n=3). (D) Log10 fold change in mRNA for CDX2, BRACHYURY, AFP, and PAX6 
following transfection of pCXLE-eGFP, KDM4C, and TET1, or no plasmid (transfection 25 
reagents) and treatment with NaAsO2 depicted relative to untreated (and no plasmid) control 
set as 1 (n=4). Conserved outcomes between cell lines (▼). Asterisks denote level of 
significance for representative outcomes for H9 (*p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001). 
30 
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Supplementary Figure 1. Effect of hypoxia versus normoxia on measures of hESC 
phenotype, dioxygenase expression and function and oxidative stress as assessed in 
RH1 hESCs. (A) Compacted colony morphologies observed following 7 days of feeder-free 
cultivation under normoxia (21% O2) vs hypoxia (0.5% O2). Bar equals 100 µm. (B) Hypoxia 5 
enhances hESC growth over 7 days of cultivation. Bars depict the mean fold increase from 
day of seeding ± SD to each time point for each atmosphere (Seeding Density 20,000/cm2; 
n=3). (C) Representative immunocytochemical detection of OCT4, NANOG, 5mC, 5hmC 
and fluorescent staining of nuclear DNA (DAPI) after 7 days of culture. Bar equals 100 µm. 
(D) ELISA quantification of 5hmC after 7 days of culture. Bar depicts mean ± SD (n=3).  (E) 10 
Log10 fold change after 7 days in mRNA for pluripotency (OCT4, NANOG and SOX2) and 
dioxygenases (KDM4C, TET1, TET2 and TET3) in hypoxia relative to normoxia, set as 1 
(n=4). (F) Generation of ROS at days 1 (D1) and 7 (D7) of culture under normoxia vs 
hypoxia assessed by flow cytometry detection of DCF dye fluorescence emission from 
stained (CTRL + dye) and unstained cells (CTRL - dye). Bars depict mean values ± SD of n= 15 
6 (D1) and 7 (D7). (G) Hypoxia elevates steady state level of mRNA for HO-1 but not GPX1, 
GPX4, SOD1 and SOD2 assessed at 7 days of culture. Log10 fold increase in hypoxia 
treated cells relative to normoxia. set as 1 (n=4). (H) Mitochondrial membrane potential did 
not vary between cells cultured under both atmospheres for 7 days, as assessed by 
Rhodamine 123 fluorescence intensity. Bars represent mean fluorescence intensity ± SD 20 
(n=3). Conserved outcomes between cell lines (▼). Asterisks denote level of significance for 
representative outcomes for RH1 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
 
 
 25 
 
 
 
 
 30 
 
 
 
 
 35 
  
2OGDHESC_ACCEPTED_27NOV2018_II.doc     Page 32 of 69 
Supplementary Figure 2. RNA interference targeting OCT4, KDM4C and TET1/2/3 
perturbs morphological and molecular measures of pluripotency as assessed in RH1 
hESCs. (A) Log10 fold change in steady state mRNA level of the siRNA targeted genes 
(YAP1, OCT4, KDM4C, TET1, TET2, TET3 and TET1-3 concurrently) expressed relative to 
cells transfected with random sequence derived from human IDS gene (IDS-NULL) (n=4). 5 
(B) Representative colony morphology corresponding to aforementioned siRNA 
transfections.  Transfection with YAP1 and IDS-NULL siRNA have no effect on colony 
morphology, whereas targeting of OCT4, KDM4C, TET1-3 does.  Bar equals 100 µm. (C) 
Immunocytochemistry for OCT4, NANOG corresponding to aforementioned transfections. 
Transfection with YAP1 and IDS-NULL siRNA have no qualitative effect on immunostaining 10 
for pluripotency markers whereas targeting of OCT4, KDM4C, TET1-3 does. Bar equals 100 
µm. (D) Log10 fold change in steady state levels of mRNAs for pluripotency associated 
transcription factors (OCT4, NANOG, SOX2) and dioxygenases (KDM4C, TET1,2,3 and 
TET1-3) following siRNA targeting of YAP1 and OCT4 as above. Only targeting OCT4, 
results in significant changes in pluripotency or dioxygenase gene transcription. (E) Log10 15 
fold change in steady state levels of mRNAs for pluripotency associated transcription factors 
(OCT4, NANOG, SOX2) and dioxygenases (KDM4C, TET1,2,3 and TET1-3) following 
siRNA targeting dioxygenases (n=4). Consistent with effects on morphology and OCT4 and 
NANOG immunocytochemistry, targeting all dioxygenases generally results in significant 
lowering of OCT4, NANOG and other dioxygenases. Conserved outcomes between cell 20 
lines (▼). Asterisks denote level of significance for representative outcomes for RH1 
(*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
 
 
 25 
 
 
 
 
 30 
 
 
 
 
 35 
 
2OGDHESC_ACCEPTED_27NOV2018_II.doc     Page 33 of 69 
Supplementary Figure 3. RNA interference targeting KDM4C and TET1/2/3 in RH1 
hESCs lowers genomic 5hmC content and induces differentiation associated 
alterations in lineage marker expression. (A) Representative immunocytochemical 
detection of 5mC and 5hmC and fluorescent labelling of nuclear DNA (DAPI) following 
transfection with siRNAs directed against IDS-NULL, YAP1, OCT4, KDM4C, TET1, TET2, 5 
TET3 and TET1-3. Bar equals 100 µm. (B) ELISA quantification of 5hmC in siRNA treated 
cells. Bars represent mean percentage of genomic DNA +/- SD (n=3). (C) Log10 fold change 
in steady state mRNA levels after siRNA treatments expressed relative to cells transfected 
with random sequence derived from human IDS gene (IDS-NULL) set as 1 (n=4). Conserved 
outcomes between cell lines (▼). Asterisks denote level of significance for representative 10 
outcomes for RH1 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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Supplementary Figure 4. Differential effects of NaAsO2 under normoxia vs hypoxia on 
measures of hESC phenotype and dioxygenase expression and function as assessed 
in RH1 hESCs. (A) NaAsO2 disrupts undifferentiated colony morphology under normoxia but 
not hypoxia. Bar equals 100 µm. (B) Representative immunofluorescent staining for OCT4, 
NANOG, 5mC, and 5hmC, and fluorescent staining for nuclear DNA (DAPI) following 5 
treatment with NaAsO2 or not under normoxia or hypoxia. Bar equals 100 µm. (C) Log10 fold 
change in levels of mRNA for OCT4, NANOG, SOX2, KDM4C, TET1, TET2 and TET3 
following treatment with NaAsO2 under normoxia or hypoxia expressed relative to untreated 
cells in the same atmosphere, set as 1  (n=4). (D) Log10 fold change in levels of mRNA for 
germinal lineage markers CDX2, BRACHYURY, AFP and PAX6 under normoxia following 10 
treatment with NaAsO2 expressed relative to untreated cells set as 1 (n=4). (E) ELISA 
quantification of 5hmC in NaAsO2 treated and untreated cells in normoxia vs hypoxia. Bars 
represent mean +/- SD (n=3). Conserved outcomes between cell lines (▼). Asterisks denote 
level of significance for representative outcomes for RH1 (*p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001). 15 
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Supplementary Figure 5. Differential effects of NaAsO2 under normoxia vs hypoxia 
evident in measures of oxidative stress as assessed in RH1 hESCs. (A) Generation of 
ROS at days 1 (D1) and 7 (D7) of culture following treatment or not with NaAsO2 under 
normoxia vs hypoxia. ROS were determined by flow cytometry detection of DCF dye 
fluorescence emission from stained (CTRL + dye) and unstained cells (CTRL - dye) cells. 5 
Bars depict mean values ± SD of n= 6 (D1) and 7 (D7). (B) Log10 fold change in levels of 
mRNA for HO-1, and antioxidants GPX1, GPX4, SOD1, SOD2 in NaAsO2 treated cells 
under normoxia vs hypoxia expressed relative to values in untreated cells, set as 1 (n=4). 
(C) Mitochondrial membrane potential in NaAsO2 treated and untreated control cells under 
normoxia or hypoxia. Bars represent mean Rhodamine 123 fluorescence intensity ± SD 10 
(n=4). Conserved outcomes between cell lines (▼). Asterisks denote level of significance for 
representative outcomes for RH1 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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Supplementary Figure 6. Transfection with plasmids encoding KDM4C or TET1 
protects against NaAsO2 induced differentiation under normoxia as assessed in RH1 
hESCs. (A) Compacted colony morphology is protected by transfection with plasmids 
(pCXLE-) encoding KDM4C and TET1 but not eGFP, or exposed to transfection reagents 
only prior to treatment with NaAsO2 under normoxia. Bar equals 100 µm. (B) 5 
Immunofluorescent staining for OCT4 and NANOG correlate with aforementioned effects on 
colony morphology. Bar equals 100 µm. Corresponding cell nuclei depicted by DAPI 
staining. (C) Log10 fold change in mRNA for OCT4, NANOG, SOX2 in aforementioned 
treatment groups depicted relative to untreated control (no plasmid) set as 1 (n=4). (D) Log10 
fold change in mRNA for KDM4C, TET1, TET2 and TET3 in aforementioned treatment 10 
groups depicted relative to untreated control (no plasmid) set as 1 (n=4). Conserved 
outcomes between cell lines (▼). Asterisks denote level of significance for representative 
outcomes for RH1 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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Supplementary Figure 7. Transfection with plasmids encoding KDM4C or TET1 
promotes genomic 5hmC content and inhibits differentiated lineage marker 
expression despite treatment with NaAsO2 under normoxia as assessed in RH1 
hESCs. (A) Immunofluorescent staining for 5mC and 5hmC correlate with aforementioned 
effects on colony morphology. Bar equals 100 µm. Corresponding cell nuclei depicted by 5 
DAPI staining. (B) ELISA quantification of 5-hmC in pCXLE-KDM4C transfection experiment. 
Bars represent mean +/- SD (n=3). (C) ELISA quantification of 5hmC in pCXLE -TET1 
transfection experiment. Bars represent mean +/- SD (n=3).  (D) Log10 fold change in mRNA 
for CDX2, BRACHYURY, AFP, and PAX6 following transfection of pCXLE -eGFP, KDM4C, 
and TET1, or no plasmid (transfection reagents) and treatment with NaAsO2 depicted 10 
relative to untreated (and no plasmid) control set as 1 (n=4). Conserved outcomes between 
cell lines (▼). Asterisks denote level of significance for representative outcomes for RH1 
(*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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Supplementary Figure 8. Confirmation that treatment with N-acetyl-L-cysteine (+ NAC) 
promotes maintenance of undifferentiated hESC colony morphology and genomic 
5hmC content despite treatment with sodium arsenite (NaAsO2) under normoxia and 
hypoxia as assessed in (A) H9 and (B) RH1 hESCs. Supplementation of hESC culture 
media with N-acetyl-L-cysteine, a potent antioxidant, maintains the undifferentiated hESC 5 
colony morphology and genomic 5hmC content upon exposure to NaAsO2 under normoxia 
and hypoxia. Immunofluorescent staining for OCT4, NANOG, 5mC, and 5hmC, and 
fluorescent staining for nuclear DNA (DAPI) following antioxidant treatment with and without 
NaAsO2 under normoxia and hypoxia. Bar equals 100 µm. 
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Supplementary Figure 9. Confirmation effect of sodium arsenite (NaAsO2) treatment 
on measures of pluriptency and 2OG dioxygenase gene (A) and lineage marker (B) 
expression.  and genomic 5hmC content (C) under normoxia vs hypoxia following 
concurrent antioxidant treatment with N-acetyl-L-cysteine (NAC), as assessed in (i) H9 
and (ii) RH1 hESCs.  (A) Log10 fold change in mRNA for pluripotency (OCT4, NANOG and 5 
SOX2) and dioxygenases (KDM4C, TET1, TET2 and TET3) under normoxia and hypoxia 
following antioxidant treatment with NAC as assessed by RTq-PCR depicted relative to non-
NaAsO2 treatments in the presence or absence of NAC set as 1 (n=4). (B) Log10 fold change 
in levels of mRNA for germinal lineage markers CDX2, BRACHYURY, AFP and PAX6 under 
normoxia following antioxidant treatment with NAC depicted relative to non-NaAsO2 10 
treatments, set as 1 (n=4). (C) ELISA quantification of 5hmC in untreated and NaAsO2-
treated hESCs following antioxidant treatment with NAC under normoxia and hypoxia. Bars 
represent mean +/- SD (n=3). For (A and B) significance of differences in fold change 
between NAC-treated cells vs non-NAC-treated cells in each atmosphere is shown. For C, 
significance of differences within atmospheres and presence/absence of NAC is shown. 15 
Conserved outcomes between cell lines (▼). Asterisks denote level of significance for 
representative outcomes for H9 and RH1 (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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Supplementary Figure 10. Confirmation of differential effects of sodium arsenite 
(NaAsO2) on hESC under normoxia vs hypoxia evident with or without N-acetyl-L-
cysteine (NAC) on reactive oxygen species production (A), antioxidant gene 
expression (B), and mitochondrial membrane potential (C)  as assessed in (i) H9 and 
(ii) RH1 hESCs.  (A) Generation of ROS at days 1 (D1) and 7 (D7) of culture under 5 
normoxia vs hypoxia following antioxidant treatment with N-acetyl-L-cysteine as assessed by 
flow cytometry detection of DCF dye fluorescence emission from stained (CTRL + dye) and 
unstained cells (CTRL - dye). Buthionine Sulfoximine (BSO) is known to elevate ROS. (B) 
Log10 fold change in levels of mRNA Levels for HO-1, GPX1, GPX4, SOD1 and SOD2 
assessed at 7 days of culture depicted relative to non-NAC-treated, set as 1 (n=4). (C) 10 
Mitochondrial membrane potential in untreated and NaAsO2-treated cells cultured under 
both atmospheres for 7 days, as assessed by Rhodamine 123 fluorescence intensity. Bars 
represent mean fluorescence intensity ± SD (n=3). ). For (A) significance of differences 
between atmospheres is shown. For (B) significance of differences in fold change between 
NAC- vs non-NAC-treated cells in each atmosphere is shown. For C, significance of 15 
differences in mitochondrial membrane potential between NaAsO2–treated -vs non-treated 
controls, within each is shown. Asterisks denote level of significance (*p<0.05; **p<0.01; 
***p<0.001; ****p<0.0001), with conserved outcomes between cell lines denoted by inverted 
triangle (▼).  
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Supplementary Figure 11. Statistical analysis of the effects of antioxidant treatment 
under normoxia and hypoxia on levels of (A) reactive oxygen species (ROS) and (B) 
mitochondrial membrane potential (MMP) in (i) H9, (ii) RH1 and (iii) H9 and RH1 
hESCs. For each cell line and each day of assessment (D1 or 7), a one-way ANOVA was 5 
performed comparing effect of atmosphere (normoxia vs hypoxia) vs treatment (untreated 
alone, untreated+NAC, NaAsO2 alone, NaAsO2+NAC, BSO alone, BSO+NAC,), followed by 
Tukey post test for which p values are presented for the normoxia vs normoxia+NAC and 
hypoxia vs hypoxia+NAC comparisons. A t-test was performed for the normoxia vs hypoxia 
comparison.  10 
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Supplementary Figure 12. Establishment of NaAsO2 concentration treatment 
cytotoxicity range following continuous exposure of hESCs over seven days. Eleven 
concentrations of NaAsO2 over a 3 log-fold range (H9: 1x10-9 – 1x10-12 M; RH1: 3.3x10-11 – 5 
3.3x10-14 M), based on previously reported toxicity ranges for other cells was evaluated for 
effect on the viability of H9 (A) and RH1 (B). For each concentration to be tested cells were 
first seeded in the absence of NaAsO2 in triplicate replicate feeder-free cultures in a 96-well 
plate format at 1 x 104 per well (surface area per well: 0.32 cm2). After 24 hours media was 
replaced with that containing a specified concentration of NaAsO2 and cultivated over 7 days 10 
in 5% CO2 in air (21% O2) at 37oC, with medium replaced every 2 days. At the endpoint of 
culture viable cell numbers were assessed using a CellTiter-Blue® Cell Viability Assay 
(Promega, Cat No. G8080). Shown are mean +/- SD viable cell numbers in relation to 
treatment concentration. Curves depict regressions of mean values fitted by four parametric 
hill function using GraphPad Prism software (San Diego, CA, USA). From these the 15 
inhibitory concentration causing a ten percent reduction in viability (IC10) normalised to 
untreated cell cultures were determined for use in subsequent experiments. Cytotoxicity 
range finder experiments were independently confirmed in each cell line (data not shown).  
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Supplementary Figure 13. Primary and secondary antibodies used in the study, target, 
source and dilution.  
 5 
 
Supplementary Figure 14. Oligonucleotide primer sequences for genes assessed by 
RT-qPCR. These were designed in house (De Sousa laboratory) or acquired from the 
laboratory of Prof. A. Sachinidis or adapted from other published studies (Danet et al., 2003; 
Piccoli et al., 2007).  10 
 
 
Supplementary Figure 15. Schematic illustration of the siRNA-mediated knockdown 
experiments. H9 and RH1 hESCs were transfected twice at a 24-hour interval with siRNA 
directed against the mRNA of YAP1, OCT4, KDM4C, TET1, TET2, TET3 and all three TETs 15 
(TET1-3). All cultures were maintained under feeder-free conditions in mTeSR-1. Samples 
were collected for RT-qPCR, immunocytochemistry and ELISA. Abbreviation/Acronym: 12-
w, 12-well; siRNA, small interfering RNA. 
 
 20 
Supplementary Figure 16. Episomal plasmids derived for the ectopic expression of 
epigenetically-marked 2-oxoglutarate-dependent dioxygenases. Maps of the episomal 
expression plasmids created for the ectopic expression of TET1 and KDM4C in H9 and RH1 
hESCs. 
 25 
Supplementary Figure 17. StemCellNet network analysis of regulatory and physical 
interactions with TET1-3 and KDM4C 2-oxoglutarate dioxygenases.  We interrogated an 
interactive platform for retrieval and analysis of molecular networks associated with stem 
cells and their marker genes, StemCellNet (http://stemcellnet.sysbiolab.eu; [49]) to assess 
associations between dioxygenases in our study and pluripotency and non-pluripotency 30 
gene products, without (A), or with (B) mapping to stemness gene sets. Molecules are 
depicted as yellow circles in A, or circles and square in B, latter denoting non-stemness 
genes according to studies on which the StemCellNet database is based. Mapping stemness 
gene sets in B re-sizes the nodes so that the their size is proportional to the number of sets 
they belong to. The dioxygenases (defined as hubs with grey circles, or squares) appear to 35 
have a total of at least 52 physical (blue line) and 26 regulatory (red arrow) molecular 
interactions, of which 23 and 10, respectively are stemness gene associated. All 
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dioxygenases physically interact or are transcriptionally regulated by a minimum of 3 (ie. 
TET3) and as many as 26 (ie. KDM4) stemness associated genes. OCT4, NANOG and 
SOX2 all directly regulate KDM4C and TET2. OCT4 and NANOG also physically interact 
with TET1. The transcription factors SMAD2 and 3, downstream of TGF-b/activin type 1 
receptor signal transduction, regulate TET1, TET3 and KDM4C.  5 
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